IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for autism and oncology.
Genomic Services
Oncology Biomarkers and Bioinformatics
Investors
Latest news // Archive
-
Press releases
Notice of publication of annual financial report
-
Press releases
IntegraGen Announces 2016 Annual Results: Increase in operating revenues and significant improvement in operating income (+22%)
-
Press releases
Laboratoire CERBA signs licensing agreement with IntegraGen to commercialize miR-31-3p tumor expression test